[Canniseur: Short but important article of what happens in the black market when supplies become scarce. There’s a lesson in here, but one that legislators are not going to pay any attention.]
It’s a matter of supply and demand. With coronavirus shutting down the regular pipeline of cannabis into France, where marijuana is not legal, pricing has soared.
Hash seems to be a product of choice for the French, according to Merry Jane. But while nearby countries such as Morocco, Belgium and the Netherlands usually offer enough supply to satisfy demand, travel restrictions have bumped black market pricing to absolutely wild levels.
Since the coronavirus crisis took hold, “the price of a 100-gram bar of resin went from 280 euros to 500 euros in a week in Marseille,” Yann Bastiere, a senior police union official, told Reuters last week.
Of course, Marseille is not alone, Bastiere said. Bordeaux and Rennes appear to be in the same boat. And the situation is likely only to worsen as COVID-19 rages on.
There may be some hope coming down the pipe, at least for medical marijuana users, however. The country’s National Assembly recently green lit a two-year initiative aimed at offering an alternative treatment to 3,000 patients with conditions such as neuropathic pain, severe epilepsy and muscular sclerosis-related painful spasticity.
[Canniseur: I only have one thing to say about this; If liquor stores can stay open, then pot shops must stay open. Both are legal. And there is no question about those who have medical cards and use cannabis as medicine. Closing those shops is no different than closing a pharmacy. It will also drive a lot of business back to the black market. Not good.]
A new poll shows that a majority of Americans believe that cannabis dispensaries should be considered essential services that are allowed to remain open during lockdowns ordered to slow the spread of the novel coronavirus. The online poll, conducted by YouGov on March 25, found that 53% of U.S. adults believe that cannabis dispensaries should be considered essential services.
The poll asked 5,369 U.S. adults one question: “Do you believe medical marijuana dispensaries should or should not be considered essential services?” In addition to the 53% who said that medical marijuana dispensaries should be considered essential, 26% said that the businesses should not be and 21% said that they didn’t know.
With jurisdictions around the globe enacting stay-at-home orders to help contain the spread of the coronavirus, cannabis activists in several locales have argued that dispensaries provide legitimate health care services that should be permitted to remain open, just like pharmacies and doctor’s offices. On Wednesday, Steph Sherer, the founder and president of Americans for Safe Access, noted in a press release that “18 states have now declared cannabis businesses essential.”
Breaking Down The Demographics
Regionally, the YouGov poll showed the strongest support for keeping medical marijuana retailers open in the Northeast, where 57% of participants said dispensaries should be considered essential services and only 26% said that they shouldn’t. Even in the South, where support for deeming dispensaries essential was the lowest, half of the respondents said that they should be. Only a quarter said that they should not be and another 25% were unsure.
By gender, support for declaring medicinal cannabis dispensaries essential was fairly even, with 54% of men and 52% of women in favor. Only 27% of men and 26% of women disagreed and said that dispensaries are not essential.
Democrats showed the most support for keeping dispensaries open, with 62% saying they should be considered essential. Only 43% of Republicans agreed, while 52% of independent voters also said that pot shops should stay open.
By age, 54% of those 18 to 24; 59% of 25 to 34-year-olds; and 56% of those in both the 35 to 44 and 45 to 54 age groups said that dispensaries are essential. Just under half, or 47%, of those 55 and older were also in favor of keeping the retailers open.
The poll also showed that those earning $80,000 or more make up the only group by income level with a majority in favor of classifying dispensaries as essential services, with 52%. In contrast, only 48% of those earning less than $40,000 and 45% with an income of $40k to $80k agreed.
Sherer of ASA said that many of the jurisdictions that have allowed medical marijuana dispensaries to remain open during mandatory closures of nonessential businesses have enacted several of the group’s recommendations, such as “instructing medical cannabis businesses on how they can make legal temporary changes to their business plans. These include expanding delivery services, allowing curbside pickup, extending the expiration date of state-issued cannabis identification cards, and allowing telehealth visits for new and renewing medical cannabis certifications.”
“We applaud these efforts at the state level and are honored to serve governments and medical cannabis stakeholders on behalf of patients,” she said.
[Canniseur: This article points out some of the larger trends occurring all over, not just SF. People are buying more edibles, which makes complete sense. COVID19 is a respiratory disease and we need to protect our lungs by smoking less. That means, eating more cannabis! Stay safe everyone.]
When San Francisco’s shelter-in-place order was announced on March 16, many city residents ran to the grocery store to stock up on things like canned goods and toilet paper.
Other residents went straight to their local dispensary. “The day of shelter in place was the busiest day we’ve ever had,” said Eliot Dobris, a spokesperson for the Apothecarium, a dispensary with three S.F. locations. “We’ve never had longer lines than that, including 4/20 and the first days of recreational sales in the state ever. Stores were just absolutely slammed.”
Dobris said people were also buying in larger quantities than normal, though things have finally started to stabilize a bit.
While customers are purchasing with regularity, their buying habits may be changing, at least in the short term. Cannabis delivery company Eaze said that since March 9, the company has seen sales of edibles rise from 15% to 30%, while the sale of the plant itself has decreased from 25% to 17%.
Vape sales have also slid from 33% to 25%.
This could be due to the fact that inhaling smoke into the lungs can increase a person’s risk of severe coronavirus. Though there have been no studies directly linking cannabis smoking to coronavirus, the disease can cause respiratory illness, which smoking or vaping can aggravate.
Dr. Michael Matthay, the associate director of critical care medicine at UCSF, told SFGATE that research has shown that smoke inhaled into the lungs can delay the clearance of the influenza virus. “Based on prior studies with other pulmonary infections, both bacterial and viral, it is highly likely that cigarette smoking and vaping will increase the risk of coronavirus pneumonia and increase its severity, though we don’t know to what extent.”
Weedmaps, often described as the Yelp of the cannabis industry, saw similar data over the past two weeks. “We have seen increases in edible sales, primarily in California,” said Travis Rexroad, Weedmaps’ director of communications. “We hypothesize people are looking for options that place less strain on their respiratory systems and that are more discreet.”
Rexroad also said traffic to the Weedmaps site has been up as much as 46% month-over-month, and they were on pace to see the number of new users who order on Weedmaps triple from the previous month.
Eaze said that since March 12, they’ve seen a 112% increase in sign-ups in S.F., with a 150% jump in first-time deliveries through the platform.
This increase in sales, as well as cannabis dispensaries’ designation as an essential business in many states, has been reflected in marijuana company stock prices. As the financial market continues to flounder, stock prices for cannabis companies have stayed steady or risen.
Some are even suggesting the financial downturn could pave the way for legalizing marijuana in more states. Taxes generated from marijuana sales have been a huge boon for states with legalization, and it could be a new revenue stream for states suffering from lost income after the pandemic is over.
It’s also one of the few industries that’s hiring right now. Eaze spokesperson Elizabeth Ashford said the company is hoping to get more drivers since the demand is very high for delivery.
Marijuana sales might have been even larger for San Francisco dispensaries in the past two weeks, but the businesses were closed for two days before Mayor London Breed added them to the essential businesses list. Dobris said he was concerned about where residents were going to obtain their product when health and safety should be of utmost importance.
“This is a particularly important time to be aware of where cannabis is coming from,” Dobris said. “You don’t know where black-market cannabis is coming from. It’s more important than ever to get it from a reputable source.”
Once the Apothecarium was open again, the company had to decide how they would make changes in favor of social-distancing practices. The store is encouraging customers to make all their orders online and wait for a text that says their order is ready before picking it up.
Dobris said they’ve also shifted some staff members to exclusively watch for six feet of space between patrons as well as to solely be responsible for cleaning surfaces.
Ashford said that while food delivery drivers made simple changes to their job, their business isn’t quite the same. “You can’t just drop a bag of cannabis at someone’s doorstep. You still have to verify ID and get a signature,” she said. “Drivers are wearing gloves and sanitizing between deliveries.”
[Canniseur: Similar to most other legal states, Washington State believes that cannabis dispensaries are ‘essential’. And well they may be essential since the stress relief that comes with cannabis can help us all cope…a lot. “Social distancing” may keep the shops uncrowded, but the sales are steady all day. Many states are telling people they must pre-order and drive up for their orders, but that’s OK as long as product is available.]
Cannabis dispensaries in Washington will be allowed to remain open during the closure of nonessential businesses ordered by Gov. Jay Inslee on Monday. The Democratic governor issued the stay-at-home order in an attempt to slow the spread of the novel coronavirus COVID-19.
Inslee’s order went into effect for residents immediately on Monday afternoon and will be effective for businesses on Wednesday. The governor’s “Stay Home, Stay Healthy” order is slated to last for at least two weeks.
The order requires all businesses deemed non essential to cease operations that cannot be completed by workers remotely from home. Washington residents were directed to heed state public health advisories to stay home except to pursue an essential activity.
Businesses and services deemed essential are permitted to remain in operation and were directed to enact social distancing protocols to protect employees and customers. The state issued a 14-page list of “Essential Critical Infrastructure Workers” to clarify the businesses and services that will be permitted to keep their employees on the job.
Among the list are employees that work at essential businesses such as grocery stores, pharmacies, take-out restaurants, and childcare providers. The list also includes health care and public health workers and worksites including hospitals, doctor’s offices, and other medical facilities such as blood banks and “cannabis retailers.”
Social Distancing Is Key
To stay open for business, cannabis retailers are required to limit the number of customers that are permitted in the store at one time and to initiate social distancing protocols. The Washington State Liquor and Cannabis Board (WSLCB) has also allowed dispensaries to allow customers to pick up their orders outside the business at curbside, a practice previously only permitted for medical cannabis patients.
“Our intent is to allow additional ways for you to engage your customers without having to have your doors open for business,” the agency wrote.
The WSLCB has also allowed licensed bars and restaurants to offer delivery and curbside pickup of spirits, wine, and beer. Restaurants can include beer or cider in growlers, kegs, or factory-sealed containers while wine and liquor must be offered only in containers sealed at the factory. Orders from restaurants must also include food.
“Our goal is to do whatever we can to help businesses during this time,” said Brian Smith, communications director at the Liquor and Cannabis Board. “We can’t change what’s in the law, but we can do other things.”
Washington joins several other jurisdictions that have determined that cannabis retailers can remain open during mandatory closures called in response to the ongoing coronavirus pandemic, including Michigan, New York, California, and Ohio.
[Canniseur: This is so not surprising. Of course, sales have spiked! Is there a better stress reliever than cannabis? I don’t think so. All the pharmaceutical ‘stress relievers’ have issues with side effects or addiction. Cannabis is perfect for stress relief. Not really addictive. The only side effects are the munchies and maybe sleepiness (depending on the cultivar) and perhaps dry mouth. All those are easily relieved. :-)]
Millions of Americans are confined to their homes due to the COVID-19 pandemic, and that has apparently been good for the cannabis industry.
Headset, a cannabis market research company, has been monitoring how the outbreak has affected marijuana businesses around the world. On Tuesday, it reported that marijuana inventory levels had declined in most states because consumers were purchasing at higher rates than usual. In California, for example, a typical marijuana retailer had enough cannabis inventory to last nearly five weeks; now, as a result of increased demand, those retailers have enough for 3.6 weeks. The story is the same in Washington, which along with Colorado became one of the first two states to vote to legalize recreational pot use for adults back in 2012. There, retailers had enough inventory to last five-and-a-half weeks before the coronavirus pandemic; now, they have enough for 4.4.
There is an exception to the trend: Nevada, where marijuana retailers have apparently been hurt by an abrupt drop in foot traffic. COVID-19 has forced the Las Vegas strip to go dark, turning an area normally teeming with tourists into a relative ghost town. Nevada marijuana retailers now have enough inventory to last 13.8 weeks, nearly double what they had before the pandemic, according to Headset’s data.
Liz Connors, director of analytics at Headset, told the New York Times that marijuana sales spiked by more than 150% after a stay-at-home order was issued for residents in the San Francisco bay area. On March 16, Headset reported that adult use cannabis sales in Oregon were a whopping 75% higher than the preceding four Mondays before it.
“It shows that a lot of people think cannabis is just another consumer good, like beer or wine,” Connors said.
Steve Allan, the president of the California-based cannabis business Caliva, said its delivery business has seen double-digit growth thus far in March, as well as an increase in its delivery services across all of its locations. The last two weeks, Allan said, have brought “record breaking sales.”
“We know that many cannabis users rely on our products and services for their ongoing well-being, so having a delivery option that can continue to service them during these unprecedented times is something we’re proud to keep up and running, of course with the safety of our own employees and our community front of mind,” Allan said.
Shareef El-Sissi, the CEO of the California cannabis company Eden Enterprises, said that the pandemic has been a watershed moment for the industry.
“I believe cannabis retail will never be the same. Retailers have been forced to pivot towards a digital first approach and customers have quickly adjusted to the new norm,” El-Sissi said. “When the quarantining is over, I think customers will continue to use digital channels to purchase cannabis. This is more inline with the order online, pick up in store trend sweeping traditional retail as well.” He said that the outbreak represented the “first panic buying event” for cannabis retail.”
California, like a number of other states where pot is legal, has deemed marijuana businesses “essential” during the pandemic, a recognition of its legitimacy as a medical treatment. The state is in the midst of a near-total lockdown, with residents ordered to stay home. Elsewhere around the country, people have anxiously stayed home in an effort to avoid getting infected, and to reduce community spread of the virus.
[Canniseur: Love what Mike Adams is writing here. We’re all living in a state of anxiety and Mike is getting it out there. Keep Calm. Carry on. This would seem to be the watchword of the day, but it’s not an easy thing to do. Mr. Adams lays it out in a great way, even if some of this is painful to read.]
The world is on the verge of complete and total bedlam. This godforsaken coronavirus is spreading with such intensity right now that the American public, well, it just doesn’t know what else to do but launch into full-blown panic mode. All one has to do is step inside a grocery store to see that the proverbial cheese of this so-called civilization of ours has slid right off the cracker. The fear of the unknown has the average citizen stockpiling everything from hand sanitizer to chicken wings. Even toilet paper has become a hot commodity inside the clutches of impending doom. I mean, did you ever think our advanced technological order would see a day when it was virtually impossible to get our hands on basic toiletries? Even Amazon is plumb out!
This widespread shortage of rolled wiping products seems to have sparked an abandonment of hope. Because in this ultra-bizarre rhyme of the great American hoarder, we are now witnessing an anxious nation that has also decided to amass a hefty surplus of hard liquor and marijuana. These folks are presumably of the opinion that if we are, in fact, grinding the very edge of the end of the world, or at the very least going to be forced to stay indoors for a month or more, then we better have plenty of weed to see us through the madness.
Legal marijuana is reportedly flying off the shelves from California to Massachusetts, just in case the federal government imposes mandatory confinement policies like they’ve done in Italy and now France. And while some states are okay with all of this reefer raiding, others, like Illinois, are worried rabid pot-procurers could hurt medical marijuana patients. The state issued a statement last week urging dispensaries to make sure to keep plenty of weed on hand for participants of the state’s medicinal cannabis program. Those people who need weed to combat various health conditions are to get first priority in the Land of Lincoln, the state reiterated.
[Canniseur: This is an important new business. I don’t know their business model so I can’t say if they’re viable. However, this kind of business is valuable, so maybe they’ll be able to make it. There only the first and hopefully one of many more to come.]
MedPharm Holdings is the only company in the state that holds a marijuana research and development license
A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city.
MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and dementia patients.
According to the Alzheimer’s Association, 5.8 million Americans have the disease, a degenerative brain disorder that affects a person’s memory and thinking skills. While there are drugs that help ease symptoms, they do not change the course of the disease.
Albert Gutierrez, CEO of MedPharm, sees Alzheimer’s as “one of the biggest things that’s plaguing our country now and in the future.” That’s why he’s excited about cannabis’ potential to treat it.
“We haven’t yet tapped into what this plant can really do to help alleviate the symptoms,” Gutierrez said. “We hear a lot of anecdotal evidence as far as helping with epilepsy or helping with arthritic pain… now it’s time to put the cannabinoids to the test and really understand what cannabinoids and what doses and what delivery methods really help deliver that relief.”
More than 30 states plus the District of Columbia have legalized medical marijuana, but research into the plant has been stifled because it’s still a Schedule I controlled substance under federal law.
Colorado first introduced R&D licensing in 2017 with the passage of House Bill 1367, but left it up to municipalities to individually decide if they would offer it. So far only one company — MedPharm — has ever applied for an R&D license, according to the Marijuana Enforcement Division.
Clinical trials ahead
MedPharm obtained its license from the state in 2018 and began growing cannabis and creating a variety of original drug formulas while waiting for Denver to open up city-level applications. If approved, the new license will enable MedPharm to administer clinical trials and develop drugs for them, including placebos.
During trials, MedPharm scientists plan to track how cannabinoids interact with neurological receptors through brain mapping and measuring cognitive abilities and patterns in patient demeanor. They’ll also study how THC, CBD and other cannabinoids are absorbed and metabolized in the body.
Gutierrez expects to begin the first phase of double-blind testing in the second quarter of 2020. Trials will run about six to nine months, he said.
This isn’t the first time researchers have studied the link between marijuana and Alzheimer’s. The Alzheimer’s Association funded at least two studies to look at the plant’s impact on brain inflammation, said Jim Herlihy, senior director of marketing and communication for the Colorado chapter. The results of those studies, which started in 2016 and 2017, have not yet been reported, but Herlihy is encouraged to see new research being pursued.
“The association has been exploring all legitimate avenues of research, from basic research through clinical trials, and investigating chemical components of marijuana and other plants because we understand that traditionally plants are an important source for many life-saving medicines,” Herlihy said.
“A lot of potential”
When legislators passed HB 1367, they hoped it would put Colorado at the forefront of medical marijuana research. Schools such as the University of Colorado and Colorado State University-Pueblo, which is home to the Institute of Cannabis Research, have been doing studies on the effects of marijuana on various conditions such as Parkinson’s disease and cancer. But sponsors of the bill contended there were plenty more opportunities.
“Right now, there’s more research than any one institution could possibly handle, frankly, for the next 10 years,” former state Rep. Dan Pabon said at the time.
Chad Kinney, director of the Institute of Cannabis Research at CSU Pueblo, said research is generally concentrated at universities because of the infrastructure that already exists there, including staff, laboratories and technology.
“The costs of such research tools can be a barrier for many companies, especially smaller ones, to conducting research in-house,” Kinney said by email.
Gutierrez said it cost $12 million to get MedPharm’s facility up and running. Even if big pharmaceutical companies want to get into the industry, many rely on federal funding that could be at risk if they study marijuana, he said.
Denver may also be one of the first cities to opt in to allow marijuana R&D licensing, and Eric Escudero, director of communications at the Department of Excise and Licensing, said he hopes this new opportunity will inspire others to get in the game.
“There’s a lot of potential,” Escudero said. “What Silicon Valley did for technology, Denver can do for medical (cannabis) research.”
[Canniseur: Fascinating story, but there’s one glaring error (to me anyway) of omission. Trinidad, CO has 26 active pot shops and a population of 8,072. That is a per capita ratio of about 310 people per shop or over 300 dispensaries per 100,000 people. I’d say that puts Trinidad right up there. While it is the closest city to the southern Colorado border, Trinidad has embraced cannabis like no other city I know of. They’re also making lots of revenue and creating jobs and wealth from a city that’s been beaten down for over a century.]
Now that marijuana legalization is taking hold across the country, the cannabis industry is really starting to bud. Ahh, get it? At any rate, in the 40 odd states that have legalized the leaf for medicinal and recreational use — see, there are so many legal jurisdictions that we’ve actually lost count — we are starting to witness an uprising in cannabis dispensaries, all of them dedicated to servicing the legions of cannabis customers out there champing at the bit to buy legal weed. Indeed, droves of people are standing in lines at these retail shops ready to get their hands on pot. It’s a wild scene unmatched by anything with maybe the exception of the lines to get in to see Mr. Bungle during their recent Raging Wrath shows. But other than that, we’re talking stoner fandom here, folks. Like, it’s readily apparent that America reaaally wants to be high.
Well, as with anything in this world, there’s always a group of scientific minds ready to roll up their sleeves to dissect what’s really going on out there. Marijuana is no exception. So, the folks at Verilife, which operates dispensaries in several states, recently buckled down to determine just how many marijuana dispensaries are in the United States. But they weren’t going to stop there, no siree. They also wanted to find out which states and cities had the most dispensaries and which ones were contributing the most tax revenue to their respective pot. Hello? Is this thing on?
While states like California, Washington and Colorado obviously led the pack in terms of collecting tax revenue from the sale of legal weed, some of the results of this exploration into dispensaries might surprise you. So, without further a due, here are the 10 states with the most dispensaries per capita.
Man, no wonder the Golden State is having such a hard time taking its cannabis trade into the realm of the legit. The study finds it only has 1.6 marijuana dispensaries per 100,000, which hardly seems enough to service all of those in need. Nevertheless, the state still threw down $354 million in tax revenue in 2018. Sure, that’s a bit lower than the initial projections, but it’s still more than any other legal state. Two of its cities have more dispensaries than anywhere else. It looks like the best place to find weed is in Cathedral City (12th in the nation) and Santa Cruz (25th). They have 11.8 and 6.2 marijuana dispensaries per 50,000, respectively, the study finds.
The state recently launched its recreational sector after running a medical marijuana program for several years. It has 1.7 dispensaries per 100,000, according to the study, contributing in the neighborhood of $2.4 million in pot taxes. Incidentally, however, none of its cities made the list of most dispensaries.
It only stands to reason that a state that is home to jurisdictions where gambling and prostitution are legal should be on the list of most marijuana dispensaries, as well. The study shows that the Silver State has 2.4 dispensaries per 100,000. These operations are contributing $69.8 million a year in tax revenue. Still, none of its cities ranks among those with the most dispensaries.
7. New Mexico
The state has been pushing recently for recreational marijuana, but it’s probably going to have to settle for its medicinal sector for a while longer. Still, it’s not too shabby based on the number of available dispensaries. The state has 5.2 dispensaries per 100,000, and it is collecting $9 million in annual tax revenue. It has only one city on the list of most dispensaries. Santa Fe came in at 28th with 5.9 per 50,000.
One of the first states in America to legalize for recreational use, Washington has 6.2 cannabis dispensaries per 100,000. It also came in second nationwide in terms of producing money, the study finds, generating $319 million in tax revenue per year. It is also where you can find a handful of cities that topped the most dispensaries list. Bellingham (8.8 dispensaries) and Olympia (8.6) came in at 20 and 21, respectively. Spokane (5.9) made the cut at 27th, while Everett (5.8) sits at 28th.
While it might not sound like there would be too many places to buy weed in the Last Frontier, it’s slinging more green than one might think. The state has 12.7 marijuana dispensaries per 100,000, giving way to $10.8 million in annual tax revenue. Unfortunately, though, none of its cities had enough dispensaries per capita to make the list.
Another one of the first states in the nation to make legal marijuana a reality for adults 21 and older sits high on the list. The study finds that Colorado has 14.1 cannabis dispensaries per 100,000. It also ranks in at third on the list for most tax revenue collected, pulling down $266 million per year. And there is a slew of cities where it might seem a dispensary is on every corner. Pueblo (16.6 dispensaries) ranks third in the nation, followed by Denver (14.9) in fifth place. On down the list is Boulder (12.1) at 11th and Colorado Springs (11.7) at 13th.
While we don’t hear too much about the cannabis trade in Montana, it is one of the leading states in the nation for most dispensaries per capita. The study shows it has 15.1 dispensaries per 100,000. But it only pulls in roughly around $1.8 million per year in tax revenue. Even still, a number of its cities have the most pot shops in the nation. Missoula (18.1 dispensaries) ranks in at numeral uno in the country. The next is further down the line. Billings, which sits at 22nd on the list, has 7.3 dispensaries per 50,000.
The state’s medical marijuana sector is set up for big things, the study finds. It is home to 15.6 cannabis dispensaries per 100,000, but most of these establishments are apparently starving to death. These operations are only producing around $70,000 in annual tax revenue. But its cities are set up to sell more weed than any other spot in the nation. Moore (13.1 dispensaries) comes in at 7th on the list, followed by Edmond (12.5) at 9th. But it doesn’t stop there. Oklahoma City (10.6) and Norman (10.5) fall in at 14th and 15th, respectively. Tulsa (10.1) and Lawton (9.6) make a showing at 17th and 18th, and so does Enid (7.0), Broken Arrow (6.5) and Midwest City.
Oregon should be nicknamed the Dispensary State. The study finds it has 16.5 dispensaries per 100,000, coming in at 4th ($94.4 million) in the nation for collecting tax revenue. Medford (17.1) is the second leading city in the country for the most dispensaries. Eugene (16.1) comes in at 4th, Portland at 6th, Salem 8th, and Bend at the 10th spot. Three more Oregon cities (Corvallis, Springfield, and Beaverton) also made the cut, the study shows.
TELL US, how many cannabis dispensaries or shops are near where you live?